(Q36735774)

16 August 2017

title

Drug policy for visceral leishmaniasis: a cost-effectiveness analysis (English)

1 reference

cost-effectiveness analysis

16 August 2017

main subject

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

3

1 reference

16 August 2017

7

Boelaert M

1 reference

16 August 2017

Vanlerberghe V

1

1 reference

16 August 2017

Diap G

2

1 reference

16 August 2017

Meheus F

4

1 reference

16 August 2017

Gerstl S

5

1 reference

16 August 2017

Van der Stuyft P

6

1 reference

16 August 2017

publication date

1 February 2007

1 reference

Tropical Medicine and International Health

16 August 2017

published in

1 reference

16 August 2017

volume

12

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

274-283

1 reference

Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01782.X

Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01782.X

Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01782.X

Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01782.X

10.1111/J.1365-3156.2006.01782.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference